Clinical Trials Directory

Trials / Completed

CompletedNCT03769233

Mindfulness for Emerging Adults Experiencing Anxious and/or Depressive Symptoms

A 5-week Mindfulness Program for Emerging Adults Experiencing Anxious and/or Depressive Symptoms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
York University · Academic / Other
Sex
All
Age
18 Years – 29 Years
Healthy volunteers
Not accepted

Summary

Emerging adults (EA; 18 to 29 years old) in Canada are among the age group with highest risk of developing mental health issues. Despite this, they experience especially long wait-times for mental health services. To date, there has been minimal research into developmentally appropriate treatment options for the EA population. Mindfulness-based interventions (MBIs) are emerging as a potential treatment to address this need. MBIs are group-based psychological treatments for coping with distress, with the goal of improving mental health. Unfortunately, these 'traditional' MBIs are very demanding in terms of time and homework and are therefore not sufficiently feasible for the demanding schedules of EA university students. Instead, recent studies suggest a role for briefer MBIs in addressing mental health symptom burden, well-being and reducing acute stress symptoms. The brevity of these interventions make them theoretically better suited for EA university populations. High quality research, including controlled clinical trials are needed to demonstrate whether MBIs can provide efficacious treatment to improve the lives of EA university students. The current study will test the efficacy of a five-week MBI baseline within-subject controlled trial.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindfulness-based InterventionMBI will be delivered in group format, 90 minutes per week, for 5 consecutive weeks with 6-15 participants per group.

Timeline

Start date
2018-12-14
Primary completion
2019-05-01
Completion
2019-05-01
First posted
2018-12-07
Last updated
2021-04-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03769233. Inclusion in this directory is not an endorsement.